Dec. 14 at 2:12 PM
$EVH If EVH executes cleanly on its existing contracts, stabilizes medical cost trends, hits ~
$200M+ EBITDA by 2026, and converts backlog into predictable cash flow, then a 2–3x EBITDA multiple expansion alone could justify a
$1.5–2.5B market cap (i.e.
$12–20/share